couldos.com Report : Visit Site

Technical data of the couldos.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host couldos.com. Currently, hosted in United Kingdom and its service provider is Overoptic Systems Ltd .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/1.3.42 (Unix) PHP/5.2.17 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home virtual serial port emulator windows 7 ; serial com port monitoring ; access serial port immune power diet: amino acids and pain july 30th, 2011 brand new research from england shows that an amino acid, d-phenylalanine, provides significant pain relief for patients with a variety of chronic pain conditions, including lower back pain, herpes, and post-surgical discomfort. (this is a different amino acid than the form of phenylalanine i discussed earlier.)teamwork is crucial for the “double a” teamteamwork is the secret of using amino acids to boost your immune power. more than any other immune power nutrient, these substances must be perfectly balanced. in fact, many amino acids, like lysine and arginine, are meant to work in precisely paired ratios. to be effective as brain messengers, energy thermostat regulators and immune boosters, amino acids must be in a balanced equilibrium.however, these powerful immune enhancers can also create powerful problems if you take them carelessly. improper self-dosing is bad medicine, a one-way road to real immune trouble.disrupting amino acid balance is the chemical equivalent of dropping putty into the works of a fine swiss watch—with even more serious results.this is the reason that all of the recipes, as well as the entire immune power diet, use safe, complementary, balanced amino acids. for the few conditions where i prescribe separate amino acids, they are safe in the doses i have given.some people have problems absorbing or making certain amino acids. one of the most frequent of these conditions, called phenylketonuria, occurs when the body is unable to break down the amino acid phenylalanine, which then builds up causing mental retardation. if you have any amino acid-related problems then any changes in your amino acids could be dangerous. consult your physician.it is essential—absolutely vital—that you follow exactly the recommendations i’ve given here. taking these chemicals willy nilly, in any way that throws off your body’s fine chemical balance, can be extremely dangerous. remember, every time you pick up one of these powerful chemicals, you should treat it as though it were stamped: handle with care.*64\242\2* posted in weight loss | comments off supportive care of children with cancer: diagnosis and treatment of chemotherapy-induced pulmonary toxicity july 19th, 2011 pulmonary toxicity is a significant complication of bleomycin. less frequently methotrexate, busulfan, and ccnu have been incriminated in acute lung syndrome, which is believed to be idiosyncratic and not predictable. radiation therapy to the lung parenchyma reduces pulmonary toxicity thresholds.pulmonary toxicity from radiation and chemotherapeutic agents may be partially reversible. ultimately, enough damage to the parenchymal lung tissue could result in death. i. toxicity of bleomycina. diagnosis of bleomycin toxicityslow inspiratory vital capacity and pulmonary capillary blood volume appear to be the proper lung function assessments that specifically reflect alterations induced by bleomycin.diffusion capacity of carbon monoxide (dlco) is not a suitable parameter to monitor pulmonary toxicity induced by bleomycin specifically when it is part of a multidrug regimen.a. investigators have found a poor correlation betweendlco and lung toxicity, and dlco fails to predict the development of serious bleomycin lung toxicity in the majority of patients. when a low dlco is encountered, look at other parameters as well (see b. below).the clinician should decide to continue bleomycin when it is in the best interest of patient care.i. bleomycin may be stopped inappropriately after low dlco measurement. dlco <65% has a high false positive incidence when used as the standard for withholding chemotherapy.ii. when a low dlco is encountered, examine and consider other parameters of lung function before discontinuing bleomycin.b. it is important to monitor for respiratory system and chest x-ray abnormalities during bleomycin treatment, as these will be the earliest signs of lung toxicity inmost patients.i. the combination of respiratory symptoms and an abnormal chest x-ray is the earliest manifestation in many patients.ii. therefore, a careful history of respiratory symptoms and regular chest x-rays is more likely to detect clinically significant bleomycin lung toxicity than the dlco.iii. diffuse infiltration with tumor, interstitial pneumonias, generalized pulmonary infections such as pneumocystis pneumonia, and bleomycin nodularity may have similar signs and symptoms.iv. an aggressive approach is justifiable because the consequence of stopping bleomycin in a patient with a curable cancer may be as devastating as continuing bleomycin in one at risk of bleomycin lung damage.b. factors contributing to bleomycin toxicitythe serum half-life of bleomycin can be increased in the presence of renal dysfunction such as that induced by cisplatin. monitor renal function closely when patients are receiving both bleomycin and nephrotoxic chemotherapeutic agents.3. the administration of oxygen in high concentrations, (e.g., during general anesthesia) may cause fulminate respiratory failure in patients previously treated with bleomycin.c. modifications for pulmonary toxicitybleomycin lung toxicity remains an unpredictable side effect by comparison with the toxicities of many other anticancer drugs. therefore, it would be advisable to avoid bleomycin in situations in which other drugs can be substituted without compromising results.d. late effectsbleomycin pulmonary toxicity may be reversible. a decreased force vital capacity and dlco in the first 15 months after treatment, in terms of long-term follow-up, did not predict outcome.*39\168\2* posted in cancer | comments off understanding tests for hiv: who should get tested-behaviors that run the risk of exposure to hiv july 5th, 2011 some of the following behaviors run a high risk of exposure to hiv, and the people who engage in the behaviors will find it in their best interests to get tested. other behaviors run a lower risk, and the people who engage in them might want to get tested. high-risk behaviors. the behaviors that run the highest risk of exposure to hiv are injecting drugs and having sex with gay or bisexual men. hemophiliacs who received clotting factors before 1986 also have had a high risk of exposure to hiv. having sex regularly with anyone who injects drugs, has gay sex with men, or has hemophilia also runs a high risk. among people with these behaviors, the frequency of hiv infection ranges from 10 percent to 70 percent, meaning that somewhere between 1 out of 10 and 7 out of 10 are infected. people with these levels of risk of infection should be tested. the risks of hiv infection, and the recommendation for getting tested, differ in different parts of the country. in the northeast, 20 percent to 70 percent of those who regularly use drugs intravenously are infected. in such areas as denver, tampa, and los angeles, only 5 percent or fewer of those who regularly use drugs intravenously are infected, a risk of 1 in 20. the risk of infection among men who have gay sex is more consistent throughout the country, ranging from 20 percent to 50 percent. for people with hemophilia, the risk of infection was constant in different parts of the country. the reason is that the clotting factors used for therapy were prepared and distributed throughout the united states from a central location. (it should be emphasized that these clotting factors are now considered safe because the blood is screened and because the factors are treated to eliminate hiv.) in any case, those who will find it in their best interests to get tested are people who use drugs intravenously; or people who have sex with gay or bisexual men; or hemophiliacs who received clotting factor before 1986; or people who regularly have sex with any of the above or with people known to have hiv infection. people who have high rates of infection

URL analysis for couldos.com

http://couldos.com/category/weight-loss/
http://couldos.com/2011/05/the-identifiable-causes-of-cancer/
http://couldos.com/category/womens-health/
http://couldos.com/category/anti-depressants-sleeping-aid/
http://couldos.com/category/cancer/
http://couldos.com/2010/06/planning-for-good-nutrition-safeguarding-food-supply/
http://couldos.com/category/mens-health-erectile-dysfunction/
http://couldos.com/category/diabetes/
http://couldos.com/2011/07/
http://couldos.com/2011/02/type-ii-diabetes-and-weight-problems-slow-two-step/
http://couldos.com/comments/feed/
http://couldos.com/category/allergies/
http://couldos.com/category/healthy-bones-osteoporosis-rheumatic/
http://couldos.com/2011/01/rheumatoid-arthritis-exercises-for-people-with-controlled-joints/
http://couldos.com/page/2/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: COULDOS.COM
Registry Domain ID: 1533467238_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.danesconames.com
Registrar URL: http://www.danesconames.com
Updated Date: 2018-12-26T05:55:26Z
Creation Date: 2008-12-17T09:49:32Z
Registry Expiry Date: 2019-12-17T09:49:32Z
Registrar: Danesco Trading Ltd.
Registrar IANA ID: 1418
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +357.95713635
Domain Status: ok https://icann.org/epp#ok
Name Server: NS0.HQHOST.NET
Name Server: NS1.HQHOST.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2019-02-03T18:11:32Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Danesco Trading Ltd.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =couldos.com

  PORT 43

  TYPE domain

DOMAIN

  NAME couldos.com

  CHANGED 2018-12-26

  CREATED 2008-12-17

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS0.HQHOST.NET 88.214.192.200

  NS1.HQHOST.NET 88.214.228.200

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .